Skip to main content
Top
Published in: Malaria Journal 1/2013

Open Access 01-12-2013 | Research

Gametocyte carriage in Plasmodium falciparum-infected travellers

Authors: Catherine H Roberts, Margaret Armstrong, Ewa Zatyka, Samuel Boadi, Simon Warren, Peter L Chiodini, Colin J Sutherland, Tom Doherty

Published in: Malaria Journal | Issue 1/2013

Login to get access

Abstract

Background

Gametocytes are the sexual stage of Plasmodium parasites. The determinants of gametocyte carriage have been studied extensively in endemic areas, but have rarely been explored in travellers with malaria. The incidence of gametocytaemia, and factors associated with gametocyte emergence in adult travellers with Plasmodium falciparum malaria was investigated at the Hospital for Tropical Diseases in London.

Methods

Clinical, parasitological and demographic data for all patients presenting with P. falciparum malaria between January 2001 and December 2011 were extracted from a prospective database. These data were supplemented by manual searches of laboratory records and patient case notes.

Results

Seven hundred and seventy three adult patients with laboratory-confirmed P. falciparum malaria were identified. Four hundred and sixty five (60%) were born in a country where malaria is endemic. Patients presented to hospital a median of four days into their illness. The median maximum parasite count was 0.4%. One hundred and ninety six patients (25%) had gametocytes; 94 (12%) on admission, and 102 (13%) developing during treatment. Gametocytaemia on admission was associated with anaemia and a lower maximum parasitaemia. Patients with gametocytes at presentation were less likely to have thrombocytopenia or severe malaria. Patients who developed gametocytes during treatment were more likely to have had parasitaemia of long duration, a high maximum parasitaemia and to have had severe malaria. There was no apparent association between the appearance of gametocytes and treatment regimen.

Conclusions

The development of gametocytaemia in travellers with P. falciparum is associated with factors similar to those reported among populations in endemic areas. These data suggest that acquired immunity to malaria is not the only determinant of patterns of gametocyte carriage among patients with the disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley CJ: Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010, 9: 136-10.1186/1475-2875-9-136.PubMedCentralCrossRefPubMed Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley CJ: Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010, 9: 136-10.1186/1475-2875-9-136.PubMedCentralCrossRefPubMed
2.
go back to reference Boudin C, Lyannaz J, Bosseno MF, Carnevale P, Ambroise-Thomas P: Epidemiology of Plasmodium falciparum in a rice field and a savannah area in Burkina Faso: seasonal fluctuations of gametocytaemia and malarial infectivity. Ann Trop Med Parasitol. 1991, 85: 377-385.PubMed Boudin C, Lyannaz J, Bosseno MF, Carnevale P, Ambroise-Thomas P: Epidemiology of Plasmodium falciparum in a rice field and a savannah area in Burkina Faso: seasonal fluctuations of gametocytaemia and malarial infectivity. Ann Trop Med Parasitol. 1991, 85: 377-385.PubMed
3.
go back to reference Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN: Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka. Am J Trop Med Hyg. 1991, 45: 479-487.PubMed Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN: Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka. Am J Trop Med Hyg. 1991, 45: 479-487.PubMed
4.
go back to reference Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ: Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg. 1999, 60: 1019-1023.PubMed Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ: Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg. 1999, 60: 1019-1023.PubMed
5.
go back to reference Drakeley CJ, Secka I, Correa S, Greenwood BM, Targett GA: Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes. Trop Med Int Health. 1999, 4: 131-138. 10.1046/j.1365-3156.1999.00361.x.CrossRefPubMed Drakeley CJ, Secka I, Correa S, Greenwood BM, Targett GA: Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes. Trop Med Int Health. 1999, 4: 131-138. 10.1046/j.1365-3156.1999.00361.x.CrossRefPubMed
6.
go back to reference Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M, Greenwood BM, Pinder M, Warhurst D, Tragett GA: Gambian children successfully treated with chloroquine can harbour and transmit Plasmodium falciparum carrying resistance genes. Am J Trop Med Hyg. 2002, 67: 578-585.PubMed Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M, Greenwood BM, Pinder M, Warhurst D, Tragett GA: Gambian children successfully treated with chloroquine can harbour and transmit Plasmodium falciparum carrying resistance genes. Am J Trop Med Hyg. 2002, 67: 578-585.PubMed
7.
go back to reference Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, Randall A, Alloueche A, Walraven G, Targett GA, Alexander N, Sutherland CJ: Chloroquine/sulfadoxine-pyrimethamine for Gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin Trials. 2006, 1: e15-10.1371/journal.pctr.0010015.PubMedCentralCrossRefPubMed Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, Randall A, Alloueche A, Walraven G, Targett GA, Alexander N, Sutherland CJ: Chloroquine/sulfadoxine-pyrimethamine for Gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum. PLoS Clin Trials. 2006, 1: e15-10.1371/journal.pctr.0010015.PubMedCentralCrossRefPubMed
8.
go back to reference Blagborough AM, Sinden RE: Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro. Vaccine. 2009, 27: 5187-5194. 10.1016/j.vaccine.2009.06.069.CrossRefPubMed Blagborough AM, Sinden RE: Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro. Vaccine. 2009, 27: 5187-5194. 10.1016/j.vaccine.2009.06.069.CrossRefPubMed
9.
go back to reference Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011, 24: 377-410. 10.1128/CMR.00051-10.PubMedCentralCrossRefPubMed Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011, 24: 377-410. 10.1128/CMR.00051-10.PubMedCentralCrossRefPubMed
11.
go back to reference Paul RE, Bonnet S, Boudin C, Tchuinkam T, Robert V: Age, structured gametocyte allocation links immunity to epidemiology in malaria parasites. Malar J. 2007, 6: 123-10.1186/1475-2875-6-123.PubMedCentralCrossRefPubMed Paul RE, Bonnet S, Boudin C, Tchuinkam T, Robert V: Age, structured gametocyte allocation links immunity to epidemiology in malaria parasites. Malar J. 2007, 6: 123-10.1186/1475-2875-6-123.PubMedCentralCrossRefPubMed
12.
go back to reference Ouedraogo AL, Bousema T, de Vlas SJ, Cuzin-Ouattara N, Verhave JP, Drakeley C, Luty AJ, Sauerwein R: The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso. Malar J. 2010, 9: 281-10.1186/1475-2875-9-281.PubMedCentralCrossRefPubMed Ouedraogo AL, Bousema T, de Vlas SJ, Cuzin-Ouattara N, Verhave JP, Drakeley C, Luty AJ, Sauerwein R: The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso. Malar J. 2010, 9: 281-10.1186/1475-2875-9-281.PubMedCentralCrossRefPubMed
13.
go back to reference Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ: Plasmodium falciparum gametocyte dynamics in areas of different malaria endemnicity. Malar J. 2008, 7: 249-10.1186/1475-2875-7-249.PubMedCentralCrossRefPubMed Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ: Plasmodium falciparum gametocyte dynamics in areas of different malaria endemnicity. Malar J. 2008, 7: 249-10.1186/1475-2875-7-249.PubMedCentralCrossRefPubMed
14.
go back to reference Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O: The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011, 117: 381-392. 10.1182/blood-2010-04-202911.PubMedCentralCrossRefPubMed Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O: The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011, 117: 381-392. 10.1182/blood-2010-04-202911.PubMedCentralCrossRefPubMed
15.
go back to reference Saeed M, Roeffen W, Alexander N, Drakeley CJ, Targett GAT, Sutherland CJ: Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS One. 2008, 3: e2280-10.1371/journal.pone.0002280.PubMedCentralCrossRefPubMed Saeed M, Roeffen W, Alexander N, Drakeley CJ, Targett GAT, Sutherland CJ: Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte. PLoS One. 2008, 3: e2280-10.1371/journal.pone.0002280.PubMedCentralCrossRefPubMed
16.
go back to reference Sowunmi A, Adedeji AA, Fateye BA, Babalola CP: Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology. 2004, 129: 255-10.1017/S0031182004005669.CrossRefPubMed Sowunmi A, Adedeji AA, Fateye BA, Babalola CP: Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology. 2004, 129: 255-10.1017/S0031182004005669.CrossRefPubMed
17.
go back to reference Peatey CL, Leroy D, Gardiner DL, Trenholme KR: Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes. Malar J. 2012, 11: 34-10.1186/1475-2875-11-34.PubMedCentralCrossRefPubMed Peatey CL, Leroy D, Gardiner DL, Trenholme KR: Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes. Malar J. 2012, 11: 34-10.1186/1475-2875-11-34.PubMedCentralCrossRefPubMed
18.
go back to reference Sowunmi A, Okuboyejo TM, Gbotosho GO, Happi CT: Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments. Chemotherapy. 2011, 57: 497-504. 10.1159/000334126.CrossRefPubMed Sowunmi A, Okuboyejo TM, Gbotosho GO, Happi CT: Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments. Chemotherapy. 2011, 57: 497-504. 10.1159/000334126.CrossRefPubMed
Metadata
Title
Gametocyte carriage in Plasmodium falciparum-infected travellers
Authors
Catherine H Roberts
Margaret Armstrong
Ewa Zatyka
Samuel Boadi
Simon Warren
Peter L Chiodini
Colin J Sutherland
Tom Doherty
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2013
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-12-31

Other articles of this Issue 1/2013

Malaria Journal 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine